Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Penny Stock Screener

Technical Analysis Screener

Top Analyst Stocks

Top Smart Score Stocks

AI Analyst Top Stocks

Top Insiders Stocks

Trending Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

Top Gainers/losers/active ETFs

Trump Dashboard

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Top Online Brokers

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

STOCKS

Dyne Therapeutics (DYN)

NASDAQ:DYN

US Market

DYN

Dyne Therapeutics

Analyst Forecasts

AI Stock Analysis

Technical Analysis

Historical Prices

News & Insights

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Advertisement

Dyne Therapeutics (DYN) Stock News & Sentiment

376 Followers

Dyne Therapeutics Advances DMD Treatment with DYNE-251 Study

Company Announcements

Dyne Therapeutics Advances DMD Treatment with DYNE-251 Study

1M ago

Dyne Therapeutics: Promising Advancements and FDA Support Drive Buy Rating

Ratings

Dyne Therapeutics: Promising Advancements and FDA Support Drive Buy Rating

2M ago

Dyne Therapeutics Gains FDA Breakthrough Designation for DYNE-251

Company Announcements

Dyne Therapeutics Gains FDA Breakthrough Designation for DYNE-251

2M ago

Dyne Therapeutics: Strategic Advancements and Financial Stability Drive Buy Rating

Ratings

Dyne Therapeutics: Strategic Advancements and Financial Stability Drive Buy Rating

2M ago

Dyne Therapeutics: Promising Clinical Developments and Strategic Positioning Drive Buy Rating

Ratings

Dyne Therapeutics: Promising Clinical Developments and Strategic Positioning Drive Buy Rating

2M ago

Dyne Therapeutics Advances in Neuromuscular Therapies

Company Announcements

Dyne Therapeutics Advances in Neuromuscular Therapies

2M ago

Dyne Therapeutics’ DYNE-251 Study Update: A Potential Game-Changer for Duchenne Muscular Dystrophy

Company Announcements

Dyne Therapeutics’ DYNE-251 Study Update: A Potential Game-Changer for Duchenne Muscular Dystrophy

2M ago

More DYN News >

DYN News on the Web

2025-09-05

Why Dyne Therapeutics, Inc.’s (DYN) Stock Is Up 7.06%

AAII

Neutral

2025-08-25

Why Dyne Therapeutics, Inc.’s (DYN) Stock Is Up 6.52%

AAII

Neutral

2025-08-22

Bernstein Reaffirms Their Hold Rating on Dyne Therapeutics (DYN)

TipRanks News

Neutral

2025-08-13

Why Dyne Therapeutics, Inc.’s (DYN) Stock Is Up 5.90%

AAII

Neutral

2025-08-06

Why Dyne Therapeutics, Inc.’s (DYN) Stock Is Down 5.16%

AAII

Neutral

2025-08-04

Stifel Nicolaus Remains a Buy on Dyne Therapeutics (DYN)

TipRanks News

Neutral

2025-07-31

Does Dyne Therapeutics (DYN) Have the Potential to Rally 285.57% as Wall Street Analysts Expect?

Zacks

Neutral

2025-07-30

Stifel Nicolaus Sticks to Their Buy Rating for Dyne Therapeutics (DYN)

TipRanks News

Neutral

News Score - Last 7 Days

Neutral

DYN

Sector Average

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

This Week50%

Sector Average56%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DYN’s Media Buzz Sentiment?

Currently, no data Available

What is DYN’s weekly average amount of articles?

Currently, no data Available

What is DYN’s News Sentiment?

50% of articles about DYN were positive this week, compared to its sector average of 56%.

Healthcare Stocks that are Trending in the News

GLUEMonte Rosa Therapeutics

LHLabcorp Holdings

OCCOrthocell Ltd

GEHCGE Healthcare Technologies Inc

KRYSKrystal Biotech

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing